Question 1

What is the catalog number for Compound NP-024374?

Accepted Answer

The catalog number for Compound NP-024374 is T128059.

Question 2

Is Compound NP-024374 in stock?

Accepted Answer

Compound NP-024374 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Who manufactures Compound NP-024374?

Accepted Answer

Compound NP-024374 is manufactured by Molfinity.

Question 4

What is the estimated delivery time for Compound NP-024374?

Accepted Answer

Estimated delivery time for Compound NP-024374 is approximately 10 business day(s), depending on your location.

Question 5

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 6

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 7

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Compound NP-024374

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

Lentiviral human WFDC5 shRNA (UAS) - Lentiviral human WFDC5 shRNA (UAS, iRFP) (100)

Moxifloxacin

Moxifloxacin

Moxifloxacin

Moxifloxacin

Recombinant Human Protocadherin beta-6 (PCDHB6), partial